Forecasting the Impact of Heart Failure in the United States

Slides:



Advertisements
Similar presentations
© 2010, American Heart Association. All rights reserved. A Validated Risk Score for In-hospital Mortality in Patients with Heart Failure from the American.
Advertisements

Hernandez et al. JAMA, May 5, 2010 – Vol. 303, No. 17 Relationship Between Early Physician Follow-up and 30-day Readmission Among Medicare Beneficiaries.
“ Age-Related Differences in Characteristics, Performance Measures, Treatment Trends, and Outcomes in Patients with Ischemic Stroke ” Gregg C. Fonarow,
This graph shows the variation in birth rate over the years from 1980 until 1999, separated by age group. The birth rate of year olds stays pretty.
Reprint—AACVPR/ACCF/AHA 2010 Update: Performance Measures on Cardiac Rehabilitation for Referral to Cardiac Rehabilitation/Secondary Prevention Services.
Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.
Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population  Richard K. Cheng, MD, MS,
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Fatal and Nonfatal Cardiovascular Disease and the Use of Therapies for Secondary Prevention in a Rural Region of India by Rohina Joshi, Clara K. Chow,
Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.
Cardiorespiratory Fitness and Exercise Training in African Americans
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)  Emily C. O’Brien, PhD,
Circ Cardiovasc Qual Outcomes
by Adam J. Singer, Robert H
Circ Cardiovasc Interv
by Adolfo Correa, Sophia Greer, and Mario Sims
Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,
Relationship of Physical Activity and Body Mass Index to the Risk of Hypertension: A Prospective Study in Finland by Gang Hu, Noël C. Barengo, Jaakko Tuomilehto,
by Yehuda G. Wolf, Christopher K. Zarins, Geoffrey D
B-Type Natriuretic Peptide Testing and the Accuracy of Heart Failure Diagnosis in the Emergency DepartmentCLINICAL PERSPECTIVE by Amaali Lokuge, Louisa.
Sex-Selective QT Prolongation During Rapid Eye Movement Sleep
Early Evolution and Correlates of Urine Albumin Excretion in Patients Presenting With Acutely Decompensated Heart FailureClinical Perspective by Satoshi.
Circ Cardiovasc Qual Outcomes
Atrial Fibrillation and Mortality in Heart FailureClinical Perspective
Association of Lipids With Incident Heart Failure Among Adults With and Without Diabetes MellitusClinical Perspective by Imo A. Ebong, David C. Goff, Carlos.
CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.
Plasma Vitamin C, but Not Vitamin E, Is Associated With Reduced Risk of Heart Failure in Older MenClinical Perspective by Sasiwarang Goya Wannamethee,
Circ Cardiovasc Qual Outcomes
Treatment of Left Ventricular Assist Device Thrombosis With Extended Catheter-Directed Intraventricular Thrombolytic Therapy by Thenappan Thenappan, Allen.
Site Selection and Performance in Clinical Trials
Modest Increase in Peak VO2 Is Related to Better Clinical Outcomes in Chronic Heart Failure PatientsClinical Perspective by Ann M. Swank, John Horton,
Circ Cardiovasc Qual Outcomes
Behavior and Biology: The Basic Sciences for AHA Action
Physician and Patient Influences on Provider Performance
Plasma Free Fatty Acids and Risk of Heart FailureClinical Perspective
Circ Cardiovasc Qual Outcomes
by Thomas Monks, Martin Pitt, Ken Stein, and Martin James
Relative Distributions
Influence of Cardiac Surgeon Report Cards on Patient Referral by Cardiologists in New York State After 20 Years of Public Reporting by David L. Brown,
Contribution of Stroke to the Cochrane Stroke Group Trials Register
Circ Cardiovasc Interv
Virtual Reality in Stroke Rehabilitation
by Beverly G. Windham, Michael E
Circ Cardiovasc Qual Outcomes
Circ Cardiovasc Qual Outcomes
by Gregg C. Fonarow, Clyde W. Yancy, Nancy M. Albert, Anne B
Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart FailureClinical Perspective by A. Rogier van der Velde, Lars Gullestad,
Cardiac Remodeling in Obesity
Risk of Heart Failure Among Postmenopausal WomenCLINICAL PERSPECTIVE
Mathematical representation of Bayes theorem.
Arterial Stiffness, Central Pressures, and Incident Hospitalized Heart Failure in the Chronic Renal Insufficiency Cohort StudyCLINICAL PERSPECTIVE by Julio.
Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic DysfunctionClinical Perspective.
by Clarisse Toledo, George Thomas, Jesse D
Body Mass Index and Heart Failure Among Patients With Type 2 Diabetes MellitusCLINICAL PERSPECTIVE by Weiqin Li, Peter T. Katzmarzyk, Ronald Horswell,
Resting Ventricular–Vascular Function and Exercise Capacity in Heart Failure With Preserved Ejection FractionCLINICAL PERSPECTIVE by Selma F. Mohammed,
Pulse Pressure and Resistance Artery Structure in the Elderly
Increasing Cardiopulmonary Resuscitation Provision in Communities With Low Bystander Cardiopulmonary Resuscitation Rates by Comilla Sasson, Hendrika Meischke,
Equipoise ”Balance of forces or interests”
A. Heart failure: A challenge to the healthcare delivery system
Nancy M. Albert, PhD, Gregg C. Fonarow, MD, William T
Nat. Rev. Cardiol. doi: /nrcardio
Obesity and type 2 diabetes forecasts.
Robert C. Stanton, MD  American Journal of Kidney Diseases 
States with the largest percentage of white residents have the highest Medicare quality rankings. Percentage of population that is non-Hispanic white according.
James E. Everhart, Meena Khare, Michael Hill, Kurt R. Maurer 
Gender differences in diabetes prevalence in 2009 in the general Portuguese population patients and in patients with CAP. Diabetes prevalence is higher.
Chapter 103 Long-Term Care: The Global Impact
Lifetime heart failure risk*
Kaplan-Meir survival plots for CHD mortality (A), CVD mortality (B), and all-cause mortality (C) in men grouped by TG/HDL-C ratio of 3.5. Kaplan-Meir survival.
Jay S. Kaufman, PhD, Sam Harper, PhD  The American Journal of Medicine 
Presentation transcript:

Forecasting the Impact of Heart Failure in the United States by Paul A. Heidenreich, Nancy M. Albert, Larry A. Allen, David A. Bluemke, Javed Butler, Gregg C. Fonarow, John S. Ikonomidis, Olga Khavjou, Marvin A. Konstam, Thomas M. Maddox, Graham Nichol, Michael Pham, Ileana L. Piña, and Justin G. Trogdon Circ Heart Fail Volume 6(3):606-619 May 21, 2013 Copyright © American Heart Association, Inc. All rights reserved.

The projected increase in direct and indirect costs attributable to HF from 2012 to 2030 is displayed. The projected increase in direct and indirect costs attributable to HF from 2012 to 2030 is displayed. Direct costs (cost of medical care) are expected to increase at a faster rate than indirect costs because of lost productivity and early mortality. HF indicates heart failure. Paul A. Heidenreich et al. Circ Heart Fail. 2013;6:606-619 Copyright © American Heart Association, Inc. All rights reserved.

Projected US prevalence of HF from 2012 to 2030 is shown for different races. Projected US prevalence of HF from 2012 to 2030 is shown for different races. The prevalence of HF remains lowest among white Hispanics and highest among blacks. HF indicates heart failure. Paul A. Heidenreich et al. Circ Heart Fail. 2013;6:606-619 Copyright © American Heart Association, Inc. All rights reserved.

Projected prevalence of HF from 2012 to 2030 is shown for men and women in the United States. Projected prevalence of HF from 2012 to 2030 is shown for men and women in the United States. The prevalence of HF remains highest among men throughout the period, although it increases among both groups over time. HF indicates heart failure. Paul A. Heidenreich et al. Circ Heart Fail. 2013;6:606-619 Copyright © American Heart Association, Inc. All rights reserved.